CLINICAL_TRIALS
other
· 2026-03-03
Clinical Trial Update: A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity [Phase 3]
Summary
A Phase 3 study evaluating retatrutide (LY3437943) for maintenance of weight reduction in obesity is ongoing but not currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING